DPYSL2 and nervous system disorder: Finally, many clinical trials are currently testing drugs that inhibit CRMP2 phosphorylation, as CRMP2 is involved in various neurological disorders (Alzheimer’s disease, schizophrenia, cephalic pain, etc.)19.